Moreover, this increase in BMP2 expression was more potent in RA than OA-FLS (1.8-fold increase with IL-17A + TNF-α compared to control without cytokines in RA FLS at 12 h vs. 0.68-fold in OA FLS, **p < 0.005). This evidence concerns the gene BMP2 and rheumatoid arthritis.